Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Zhijie Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Mitophagy, Cardiolipins, Diabetic Nephropathies, Lipid Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "PRO•Run" Fund of the Nephrology Group of CEBM, The Educational Department of Liaoning Province, Department of Education of Liaoning Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Lipotoxicity plays a crucial role in the progression of diabetic kidney disease (DKD), yet the dynamic changes in renal lipid composition from diabetes to early‐stage DKD remain unclear. Free fatty acids, lactosylceramides and cardiolipin (CL) were identified as the most significantly altered lipids by quantitatively comparing targeted lipids in the renal cortex of the classic spontaneous diabetic db/db mice using high‐coverage targeted lipidomics. Further investigation into the causes and effects of decreased CL, which is a unique mitochondrial phospholipid, was conducted in mitochondria‐rich renal proximal tubular cells by using western blotting, real‐time PCR, immunohistochemistry and transmission electron microscopy. Reduced expression of cardiolipin synthase, a key enzyme in the CL synthesis pathway, and inhibition of CL‐related mitophagy were confirmed under high glucose conditions. In addition, the protective effect of CL‐targeted Szeto‐Schiller 31 in preserving mitophagy was demonstrated in both in vivo and in vitro studies. These findings provide new insights into the pathogenesis of early‐stage DKD from a lipid perspective and offer a theoretical basis for discovering new treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
- LipidALL Technologies Company Limited, Changzhou, Jiangsu, China.
ORCID-Profile: Xiaodan Liu
Förderung
- "PRO•Run" Fund of the Nephrology Group of CEBM
- The Educational Department of Liaoning Province
- Department of Education of Liaoning Province
Zitieren
APA
Li, Z., Wang, H., Liu, N., Lan, X., Xie, A., Yuan, G., Li, B., Geng, J., & Liu, X. (2025). Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70419
Vancouver
Li Z, Wang H, Liu N, Lan X, Xie A, Yuan G, et al. Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70419
BibTeX
@article{Li2025,
author = {Li, Zhijie and Wang, Hongmiao and Liu, Nan and Lan, Xiayuchen and Xie, Ailing and Yuan, Ge and Li, Bowen and Geng, Jiaxin and Liu, Xiaodan},
title = {Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70419}
}
EUVIMED